Patient radiation biological risk in computed tomography angiography procedure  by Alkhorayef, M. et al.
Saudi Journal of Biological Sciences (2017) 24, 235–240King Saud University
Saudi Journal of Biological Sciences
www.ksu.edu.sa
www.sciencedirect.comORIGINAL ARTICLEPatient radiation biological risk in computed
tomography angiography procedure* Corresponding author.
E-mail address: malkhorayef@ksu.edu.sa (M. Alkhorayef).
Peer review under responsibility of King Saud University.
Production and hosting by Elsevier
http://dx.doi.org/10.1016/j.sjbs.2016.01.011
1319-562X  2016 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).M. Alkhorayef a,*, E. Babikir a, A. Alrushoud b, H. Al-Mohammed c, A. Sulieman daDepartment of Radiological Sciences, College of Applied Medical Sciences, King Saud University, PO Box 10219, Riyadh
11433, Saudi Arabia
bDepartment of Medical Physics, Prince Sultan Military Medical City, PO Box 7897, Riyadh 11159, Saudi Arabia
cDepartment of Medical Technical, College of Health and Rehabilitation Sciences, Princess Nora Bint Abdulrahman University,
PO Box 84428, Riyadh 11671, Saudi Arabia
dPrince Sattam Bin Abdulaziz University, College of Applied Medical Sciences, Radiology and Medical Imaging Department,
PO Box 422, Alkharj 11942, Saudi ArabiaReceived 3 November 2015; revised 2 January 2016; accepted 5 January 2016
Available online 12 January 2016KEYWORDS
CTA;
Effective dose;
Medical exposure;
Radiation risk;
Computed tomographyAbstract Computed tomography angiography (CTA) has become the most valuable imaging
modality for the diagnosis of blood vessel diseases; however, patients are exposed to high radiation
doses and the probability of cancer and other biological effects is increased. The objectives of this
study were to measure the patient radiation dose during a CTA procedure and to estimate the radi-
ation dose and biological effects.
The study was conducted in two radiology departments equipped with 64-slice CT machines
(Aquilion) calibrated according to international protocols. A total of 152 patients underwent brain,
lower limb, chest, abdomen, and pelvis examinations. The effective radiation dose was estimated
using ImPACT scan software. Cancer and biological risks were estimated using the International
Commission on Radiological Protection (ICRP) conversion factors.
The mean patient dose value per procedure (dose length product [DLP], mGycm) for all exam-
inations was 437.8 ± 166, 568.8 ± 194, 516.0 ± 228, 581.8 ± 175, and 1082.9 ± 290 for the lower
limbs, pelvis, abdomen, chest, and cerebral, respectively. The lens of the eye, uterus, and ovaries
received high radiation doses compared to thyroid and testis. The overall patient risk per CTA
procedure ranged between 15 and 36 cancer risks per 1 million procedures. Patient risk from
236 M. Alkhorayef et al.CTA procedures is high during neck and abdomen procedures. Special concern should be provided
to the lens of the eye and thyroid during brain CTA procedures. Patient dose reduction is an impor-
tant consideration; thus, staff should optimize the radiation dose during CTA procedures.
 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under theCCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The exposure to X-ray radiation during imaging procedures
may generate biological effects. Ionizing radiation is capable
of cell killing by apoptosis or radiation-induced reproductive
failure, which can lead to changes in the genes involved in cell
growth regulation, loss of normal nuclear structure, degrada-
tion of DNA, and tumorigenesis (Shah et al., 2012). These
effects include cancer and hereditary effects, which increase
an individual’s lifetime risk of developing cancer or a heredi-
tary effect in future generations. Tissue reaction effects have
precise radiation dose thresholds which induce radiation risks
in relatively high doses (ICRP, 2007a). The International
Commission on Radiation Protection (ICRP) adjusted nomi-
nal radiation detriment coefﬁcients for cancer and hereditary
effects as follows: 5.5  102 and 0.2  102 S v1 for the
whole population (ICRP, 2007a). In addition to these effects,
radiation exposure has an association with certain diseases
(non-cancer effect), such as respiratory diseases, stroke, heart
diseases, and digestive disorders (Brenner and Hall, 2007;
ICRP, 2007a). Although, radiation risks of non-cancer dis-
eases at low doses remain uncertain, patient radiation doses
must be kept at a minimum value to ensure maximum patient
protection (ICRP, 2007a; Shah et al., 2012). Since the intro-
duction of angiography in 1927, X-ray instrumentation tech-
nology has advanced. Currently, computed tomography
angiography (CTA) is frequently used in the evaluation of car-
diovascular system disorders with a sensitivity and speciﬁcity
of 95% and 93%, respectively (Boesiger and Shiber, 2005;
Willinsky et al., 2003). Consequently, the use of CT in medical
imaging procedures has increased considerably over the past
several decades since its introduction in 1971 (Brenner and
Hall, 2007). The technological improvement of CT has resulted
in the development of spiral CT technology in the 1990s and
improvement of image quality in terms of temporal (165–
175 ms) and isotropic spatial resolution (0.3–0.4 mm), and in
reduction of image acquisition times, which permits angio-
graphic procedures associated with higher patient doses (Sun
et al., 2012; McCollough et al., 2009). Therefore, patient health
care has improved signiﬁcantly due to accurate diagnosis of
cardiovascular system disorders compared to other imaging
modalities (Brenner and Hall, 2007; Sun et al., 2012); however,
CT procedures convey radiogenic risk due to the high radia-
tion dose during image acquisition, which depends on age, gen-
der, and health status (ICRP, 2007b). Recent studies have
estimated that 1.5–2% (29,000 cancer cases) of the cancers
diagnosed annually in the USA are associated with CT expo-
sure (Brenner and Hall, 2007; Berrington de Gonzalez et al.,
2009). Due to the increasing concern regarding radiogenic risk
to patients during CTA procedures, a number of studies have
been published internationally, which have focused on patient
radiation during CTA procedures due to the large anatomic
volumes included and acquisition of thinner slices. A largevariability in patient radiation dose has been reported
(Mafalanka et al., 2015; Brenner and Hall, 2007; Berrington
de Gonzalez et al., 2009; Oca Pernas et al., 2014; Sabarudin
and Sun, 2013). Further, it has been reported that patient
effective doses during CTA procedures range between 2.2
and 24.4 mSv (Mafalanka et al., 2015). It addition, limited
data are available worldwide regarding patient radiation doses
and the related risk. Therefore, it is essential to evaluate
patient doses during CTA procedures to justify and optimize
the procedure and balance the beneﬁt against radiation risk
(ICRP, 2007a,b). Radiation sensitivity, which is deﬁned as
the relative vulnerability of cells, organs, or tissues to the detri-
mental effect of ionizing radiation, varies for different tissues
and organs depending on age, and physical and biological fac-
tors (ICRP, 2007a; McCollough et al., 2009). Gonads, red
bone marrow, and the lens of the eye are the most radiosensi-
tive tissues. It has been estimated that <1% of people are
extremely radiosensitive because of inherited transformations
in DNA harm-sensing or repair genes, while the remaining tis-
sues have a variety of sensitivities (ICRP, 2007a). Therefore,
estimation of organ doses is essential to estimate the risk of
procedures. Due to partial exposure of radiosensitive organs
during CTA procedures, the estimation of organ and effective
doses provide essential data regarding individual radiogenic
risk. Regular patient dose measurements are recommended
to improve clinical practice during CT procedures. Even
though the risk to an individual patient may be small, the
increasingly large number of people exposed, coupled with
the increasingly high exposure per examination, could trans-
late into many cases of cancer resulting directly from radiation
exposure during CT. The increase in patient doses in CT pro-
cedures is attributed to a tendency to increase the scanned vol-
ume during CT procedures, the possibility of overlapping
scans in advanced CT machines, repeat CT examinations,
and the use of inappropriate exposure factors. The objectives
of this study were to measure patient radiation dose during
CTA imaging and to estimate the radiation and biological
effects.
2. Materials and methods
2.1. Patient data
A total of 152 adult patients (55.3% males and 44.7% females)
underwent brain, limb, chest, pelvis, and abdomen CTA
(Table 1). The Ethics and Research Committee approved the
study and informed consent was obtained from all patients
prior to the procedure. All patients were referred for CTA pro-
cedures for a variety of clinical indications. All CTA proce-
dures were performed for clinical indications. The
angiographic procedures included cerebral, chest, abdomen,
pelvis, and limb procedures. Patient-related parameters (age,
gender, and diagnostic purpose of the examination) and radi-
Table 1 Patient data distribution according to gender for angiographic procedures.
Gender Limbs Abdomen Chest Head Pelvis Total Percentage (%)
Male 31 15 15 12 11 84 55.3
Female 14 9 11 11 23 68 44.7
Total 45 44 26 23 34 152 100
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current [mA], exposure time, slice thickness, and number of
slices) were taken into consideration.
2.2. CT machines and patient dose measurements
A 64-slice CT scanner (MSCT, Toshiba Sensation Aquilion 64;
Otawara, Japan) was installed in 2011. The MSCT consists of
64  0.5 mm detector rows, and a maximum gantry rotation
speed of 0.4 s. All quality control tests were performed on
the machine prior to data collection. All the parameters were
within acceptable ranges. Radiation dose estimates were deter-
mined using the volume CT dose index (CTDIvol) in mGy and
the dose-length product (DLP) in mGycm, as provided on the
scanner console. Organ doses were estimated using normalized
CTDI values, as published by the ImPACT group (ImPACT,
2011).
2.3. Effective and organ doses estimations
DLP (mGycm) was used to estimate the organ-equivalent
dose (H) using software provided by the National Radiological
Protection Board (NRPB-SR250, 1996) and patient exposure
parameters.
The organ equivalent dose (mSv) is given by
HT ¼
X
R
wR DT;R ð1Þ
where DT,R indicates the mean absorbed dose to the organ (T)
from radiation (R) and wR is the radiation-weighting factor
(ICRP, 2007b).
2.4. Cancer risk estimation
The overall cancer risk per procedure was obtained by multi-
plying effective dose with the risk coefﬁcients (fT) (5.5 S v
1).
The risk (RT) of developing cancer in a particular organ (T)
was determined by multiplying the mean organ-equivalent
(HT) dose with the risk coefﬁcients (fT) obtained from ICRP
103 (ICRP, 2007a). The risk of genetic effects in future gener-
ations was obtained by multiplying the mean dose to the ovar-
ies by the risk factor (ICRP, 2007a) as follows:Table 2 Show image acquisition parameters according to gender.
Gender Age (year) Total time (s)
Male 51.4 ± 19.41
25–88
61.99 ± 21.43
18.60–121.00
Female 59.7 ± 20.70
19–100
56.78 ± 21.45
16.00–16.00
* Constant potential.RT ¼ fT HT ð2Þ3. Results
The mean age of the 152 patients was 51.3 and 59.7 years for
males and females, respectively, as presented in Table 2. Con-
stant tube potential and pitch were used with manual settings
of tube current, as shown in Table 2. The measured patient
doses with respect to CTDIvol (mGy), DLP (mGycm), and
effective dose values for all patients are shown in Table 3.
The results are presented per department, per procedure, and
per gender, according to the examination type. The results of
patient dose showed a large variation. The highest dose values
were for the cerebral CTA procedure, while the lowest dose
values were for the lower limb procedure. This difference
may be due in part to the type of procedure and exposure
parameters, which were based on patient demographic data
and covered volume. The lens of the eye received 41.2 mSv per
procedure, on average (Table 4). Table 5 presents the esti-
mated cancer risk for both genders. The cancer risk order of
magnitude ranged between 103 and 104 per procedure. Thus
the risk value is considered high when compared with conven-
tional CT chest procedure, which ranges between 105 to 106
(Sulieman et al., 2015).
4. Discussion
4.1. Patient dosimetry
CTA examinations in adult patients have contributed greatly
to the diagnosis of different diseases; however, the radiation
exposure to the patient is signiﬁcantly higher compared with
other radiologic examinations. Table 2 represents the scan
parameter per procedure. A constant voltage potential
(120 kVp) was used for CTA procedures with variable mAs,
which ranged from 100 to 250. This variation in mAs could
be attributed to different patient size, and also differed based
on the different type of CTA examination (i.e., lower limbs,
abdomen, chest, head, and pelvis). In addition, variation
between DLP values may have resulted from differences in
mAs, and pitch values (proportion inverse to the dose) for
all CTA examinations. In general, the patient radiation doseTube voltage Tube current (mA) Pitch
120* 150 ± 70
(100–250)
0.92
120* 150 ± 70
(100–250)
0.92
Table 3 Patients’ doses during CTA procedures.
Procedure CTDIvol
(mGy)
DLP
(mGycm)
Eﬀective dose
(mSv)
Cerebral 70.8 ± 4
(60.2–80.0)
1082.9 ± 290
(809.0–1272.8)
2.3 ± 0.6
(1.7–2.7)
Chest 30.5 ± 13
(20.0–42.0)
581.8 ± 175
(307.0–828.4)
8.1 ± 2.6
(4.3–11.6)
Abdomen 37.7 ± 16
(18.0–40.0)
516.0 ± 228
(446.0–749.0)
7.4 ± 3.4
(6.7–11.2)
Pelvis 27.2 ± 10.0
(11.1–34.5)
568.8 ± 194
(405.0–709.0)
8.9 ± 3
(6.1–10.6)
Lower
limbs
14.7 ± 8
(7.0–25.0)
437.8 ± 166
(357.0–884.0)
3.9 ± 1.4
(3.2–8.0)
Table 4 Organ dose equivalent for certain radiosensitive
organs during CTA procedure.
CT
procedure
Organ equivalent dose (mSv)
Eye
lens
Thyroid Breast Uterus Ovaries Testis
Cerebral 41.2 2.2 0.03 0 0 0
Chest 0.1 1.4 13.3 0.04 0.05 0
Abdomen 0 0.05 0.6 7.4 7.5 0.6
Pelvis 0 0 0.02 24 23 1.6
Table 5 Patient organ dose and risk estimation per gender
and procedure type.
CTA
procedure
Organ Organ
equivalent
dose (mSv)
Risk
coeﬃcient
104
Cancer
probability
106
Cerebral Thyroid 2.2 33 73
Chest Breast 12.3 112 1377
Abdomen Uterus 24 143 3432
Pelvis Ovaries 23 11 253
Pelvis Testis 1.6 20# 32
Overall
cancer risk
per procedure
# Hereditary.
238 M. Alkhorayef et al.is proportional to tube current–time product (mAs). There-
fore, reduction of the tube current will also decrease the radi-
ation dose by the same value. In an ideal situation, image
acquisition parameters were adjusted according to scanned
anatomy. Table 3 shows the mean and range of values of
CTDIvol (mGy), DLP (mGycm) and effective dose (mSv)
per procedure. Effective dose, which is gender-averaged and
risk-adjusted dosimetric quantity, allows the estimation of
nominal risk coefﬁcients for uniform external radiation expo-
sure. It also allows the comparison with patient doses in other
imaging modalities and reference levels. The highest radiation
dose per CTA procedure involved cerebral CTAs and the high-
est effective dose involved pelvic CTAs. This ﬁnding can be
explained given that the trunk includes the most radiosensitive
organs with tissue weighting factors. The results obtained in
this study are within the ranges reported in previous studies(Fink et al., 2011; Loader et al., 2012; Qi et al., 2014). There
are many factors that affect the radiation dose from CTA.
These factors include beam energy, tube current, rotation or
exposure time, slice thickness, pitch, and dose reduction tech-
niques, such as the tube current modulation technique. It has
been reported that the effective dose from CT procedures
can often approach or exceed levels known to increase the
probability of cancer (Brenner and Hall, 2007).
4.2. Dosimetry of critical and non critical organs
Estimation of patient radiation risks due to CT procedures is
essential to assess procedure justiﬁcation (beneﬁt versus the
expected risk). CT procedures entail direct irradiation of cer-
tain radiosensitive organs, such as the lens of the eye, breast,
thyroid, or gonads, based on the type of the procedure
(Table 4). The radiation risk of CT procedures is directly pro-
portional to organ doses. Other adjacent organs which lie
nearby the ﬁeld will possibly be exposed to considerable doses
(Table 4). The lens of the eye is a radiosensitive organ and
radiation effects include opacities and visual impairment (cat-
aracts). In this study the lens of the eye received 41.2 mSv per
cerebral CTA procedure. This value is lower compared to that
of previous studies (Suzuki et al., 2010). Suzuki et al. (2010)
reported the dose to the lens of the eye during CT of the brain
ranging between 50.9 and 113.3 mSv per CT brain procedure.
Recently, the ICRP (2012) reported that the radiation effect on
the lens of the eye and circulatory diseases is lower than that
previously considered based on linear dose–response assump-
tions (ICRP, 2012). The threshold of the lens of the eye
decreased from 5.0 to 0.5 Gy, while the threshold of occupa-
tional exposure, the equivalent dose limit for the lens of the
eye, was reduced from 150.0 mSv/year to only 20.0 mSv/year.
The mechanism underlying cataract induction; however,
whether deterministic (tissue reaction) or stochastic (non-
threshold), has yet to be determined (ICRP, 2012). Although,
the dose limit was signiﬁcantly reduced, a cataract of the lens is
a non-cancerous and non-fatal effect compared to cancer and
non-cancer effects induced by radiation, such as coronary
heart disease. In light of this information, the lens of the eye
dose during CTA and other imaging procedures should be
reassessed and rigorous justiﬁcation of the procedure is
needed. Moreover, other alternatives should be considered,
such as magnetic resonance imaging (MRI). The breast has
the highest equivalent dose for chest procedures with the high-
est cancer probability compared to the thyroid and uterus
(Einstein et al., 2007). Therefore, CT procedures of the chest
in girls and young females need to be carefully justiﬁed in view
of the high radiation dose and probability of cancer.
4.3. Cancer risks
Table 5 presents the radiation risk per CT procedures for
selected organs that received the highest radiation dose per
each procedure. The thyroid has a high radiosensitivity in both
males and females. Three organs have high carcinogenic
radiosensitivity in females (i.e., breast, uterus, and ovary)
and one organ has high carcinogenic radiosensitivity in males
(i.e., testis). Organ doses were converted to radiation risks
using the age- and gender-speciﬁc patient risk values provided
by the ICRP (2007a). The thyroid, breasts, uterus, ovaries, and
Radiation biological risk in computed tomography angiography 239testes are the organs with the highest exposure to radiation,
and thus the highest risk per procedure because these organs
are exposed to primary radiation during cerebral, chest, abdo-
men, and pelvis procedures, respectively. It has been reported
that females are 1.6 times more radiosensitive to radiation than
males (ICRP, 2007a). Therefore, extra concern should be paid
to female patients, especially young patients. Patient age is a
crucial factor in cancer risk estimation. It has been estimated
that increasing the patient age (years) from 20 to 80 resulted
in a reduction in patient risks of a factor of 5 for CT abdomen
(Huda and He, 2012). Table 5 shows the cancer risk induction
per procedure. The uterus and ovaries were exposed to the
highest dose compared to other organs. The risks of
radiation-induced cancer and hereditary effects are illustrated
in Table 5 based on the risk coefﬁcient from the ICRP
(2007a). As shown in Table 5, the patient cancer risk is one
cancer case per 1000 CTA chest procedures and three cancer
cases per 1000 CTA abdomen procedures. The least risk for
CTA procedures is thyroid cancer. The hereditary effect is
low (three genetic effects per 100,000 procedures). The overall
patient risk per CTA procedure ranges between 13 and 49 can-
cer risks per 105 procedures (Table 6). The highest cancer risk
for patients occurs during chest (45  105), abdomen
(41  105), and pelvis ((49  105) CTA procedures (Table 6).
This ﬁnding can be attributed to the fact that radiosensitive
organs are exposed to the primary beam, hence the effective
dose is higher compared to cerebral and extremity CTAs.
Huda and He (2012) reported that at radiation intensity, the
radiation induced cancer for females are obviously higher than
those for males, while for procedures that incorporate the pel-
vic region, radiation risks in males were slightly higher than
those in females. The risks for male and females were similar
for CT abdomen. Based on the results of the current study,
it is apparent that a dose below the tissue reaction effect, such
as erythema and epilation, indicates tissue reaction effects
occur at a certain threshold [2.0 Gy (ICRP, 2007a;
UNSCEAR, 2000)]. Therefore, tissue reaction effects are not
anticipated during CTA procedures in light of current practice
standards. Certain measures are recommended in the literature
to reduce patient risk from CTA procedures, such as use of
patient dose optimization protocols, increased staff awareness,
use of advanced imaging technology, and use of lead or bis-
muth shields during CT procedures (Deak et al., 2009; Yu
et al., 2009; Sulieman et al., 2015). It is important to note that
radiation risk estimation from low-dose values has many
uncertainties due to long latent periods, which range between
several years up to decades. In addition, radiation effects can-
not be distinguished easily in low radiation dose levels from
other causes due to the long latent stage between radiation
exposure and cancer development (Berrington de Gonzalez
et al., 2009). The cancer effect has no threshold (linear non-Table 6 Overall cancer risk per procedure.
CTA
procedure
Mean eﬀective dose
(103 Sv)
Risk
coeﬃcient
(S v1)
Cancer
probability
105
Cerebral 2.3 5.5  102 13
Chest 8.1 45
Abdomen 7.4 41
Pelvis 8.9 49threshold model), hence any dose can cause cancer or genetic
mutations because any DNA damage can initiate loss of cell
division control. Therefore, radiation protection against ioniz-
ing radiation is crucial to the dose received during diagnostic
medical exposure in CTA procedures, regardless of the quan-
tity, and is highly relevant.
5. Conclusions
 Patients are exposed to considerable radiation doses. Esti-
mation of patient radiation risk helps to improve staff
awareness of radiation exposure consequences from medi-
cal procedures to keep the patient radiation dose as low
as reasonably achievable.
 Radiosensitive organs receive a signiﬁcant radiation dose
during CTA procedures, therefore rigorous reassessment
of justiﬁcation criteria and optimization measures of the
procedure are needed and other non-ionizing radiation
alternatives should be considered.
 Special concern is recommended in justifying CTA proce-
dures for young female patients. Comprehensible justiﬁca-
tion of examinations is highly recommended, and
repetition of examinations should be avoided.
 A national survey is highly recommended to establish a
national diagnostic reference level for CTA. A CTA proce-
dure is operator-dependent. Therefore, continuous training
in CTA use and safety is crucial.
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